OTC:BUDZ
WEED, INC.
A US-based cannabis operator specializing in hemp-derived cannabinoid products navigating a complex but expanding regulatory landscape.
Key Metrics
Investment Thesis
Bull Case
Investors might consider BUDZ as a distressed opportunity with significant turnaround potential if management can successfully restructure operations and generate commercial revenue in the lucrative hemp market. The company possesses inherent low fixed cost advantages typical of smaller cannabis operators, which could allow for a profitable rebound once sales stabilize. If regulatory clarity improves or new product lines launch, the current cash burn could be reversed rapidly given the lack of heavy depreciation schedules.
Bear Case
Avoiding BUDZ is prudent given the alarming negative equity position and the inability to generate any revenue from continuing operations over the last several years. The company is burning through its remaining cash reserves without a clear path to profitability, making it highly susceptible to bankruptcy or acquisition at fire-sale prices. Continued high administrative expenses relative to zero income suggest fundamental business model failures that are unlikely to resolve in the short term.
About WEED, INC.
WEED, INC. (BUDZ) operates within the cannabis sector, focusing on cultivation and distribution of hemp-derived cannabinoid products in the United States. The company targets recreational and medical markets where federal laws permit the sale of products containing less than 0.3% THC. Despite recent operational shifts, the firm maintains a presence in a high-growth, socially transformative industry with significant regulatory tailwinds.
Analysis
Management Discussion
The company reported a net loss of $510,716 in the latest period, driven by substantial general and administrative expenses totaling over $351K with no revenue to offset them. Operating cash flow turned negative at -$415,524, leading to a decline in cash reserves from roughly $290K to $159K, which severely limits strategic maneuverability. The balance sheet shows current liabilities exceeding assets by nearly $769K, indicating the firm is in a precarious financial position requiring immediate capital infusion or asset monetization.
Industry Overview
The US cannabis industry remains fragmented with significant growth potential as more states legalize adult-use and hemp markets expand. However, profitability is often elusive for smaller players facing intense competition from established giants and a challenging regulatory environment that varies by state. Success requires navigating complex compliance costs while managing cash flow tightly to survive until market share consolidation occurs.
Financial Statements
Income Statement
Balance Sheet
Cash Flow
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | $0 | $0 | $0 |
| Cost of Revenue | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 |
| Operating Expenses | $1.5M | $770.6K | $530.0K |
| Operating Income | $-1.5M | $-770.6K | $-530.0K |
| G&A | $567.2K | $394.6K | $351.1K |
| D&A | $111.4K | $52.4K | $22.6K |
| Depreciation | $106.1K | $49.8K | $20.0K |
| Amortization | $2.5K | $2.6K | $2.6K |
| Other OpEx | $938.1K | $374.8K | $177.7K |
| Non-Operating Income | $-22.8K | $0 | $0 |
| Interest Expense | $117.1K | $45.4K | $5.1K |
| Pre-Tax Income | $-1.5M | $-770.6K | $-530.0K |
| Income Tax | $0 | $980 | $399 |
| Continuing Ops | $-1.5M | $-771.5K | $-530.4K |
| Discontinued Ops | $0 | $0 | $0 |
| Net Income | $-1.5M | $-31.6K | $-510.7K |
| Minority Interest | $0 | $0 | $0 |
| Net to Common | $-1.5M | $-31.6K | $-510.7K |
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Current Assets | $342.1K | $319.9K | $189.9K |
| Long-Term Assets | $1.3M | $584.2K | $548.5K |
| PP&E (Net) | $1.2M | $516.3K | $496.4K |
| Goodwill | $0 | $0 | — |
| Operating Leases | $44.1K | $31.7K | $18.5K |
| Other LT Assets | $38.8K | $36.2K | $33.6K |
| Total Assets | $1.6M | $904.1K | $738.4K |
| Current Liabilities | $1.5M | $648.8K | $959.4K |
| Accounts Payable | $189.8K | $183.6K | $167.6K |
| Current Leases | $44.1K | $31.7K | $18.5K |
| Other Current Liab | $1.2M | $368.8K | $688.4K |
| Long-Term Liabilities | $0 | $0 | $0 |
| Total Liabilities | $1.5M | $648.8K | $959.4K |
| Shareholders' Equity | $169.8K | $255.3K | $-221.0K |
| Paid-In Capital | $83.8M | $83.8M | $84.2M |
| Retained Earnings | $-84.4M | $-84.4M | $-84.9M |
| Total L&E | $1.6M | $904.1K | $738.4K |
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Net Income (CFO) | $-1.5M | $-31.6K | $-510.7K |
| Non-Cash Adjustments | $689.6K | $-809.9K | $65.9K |
| Working Capital Changes | $25.5K | $-232.6K | $29.3K |
| Cash from Operations | $-813.0K | $-1.1M | $-415.5K |
| Capital Expenditures | — | $10.0K | — |
| Cash from Investing | $1.3M | $1.6M | $799 |
| Cash from Financing | $-148.7K | $-588.0K | $285.3K |
| FX Effect | $777 | $5.6K | $-799 |
| Net Change in Cash | $295.4K | $-31.0K | $-130.3K |
| Beginning Cash | — | $315.8K | $290.4K |
| Ending Cash | — | $290.4K | $159.4K |
Frequently Asked Questions
How does WEED, INC. make money?
The company's financials indicate a primary focus on product sales through cultivation and distribution channels rather than heavy manufacturing or licensing fees. With revenue reported as zero in the latest period, the business likely relies on inventory liquidation, strategic partnerships, or non-recurring transactions to sustain operations while restructuring its core commercial model.
What are the main risks for BUDZ?
The most significant risk is the complete lack of revenue generation and a substantial net loss that has eroded shareholder equity to nearly $221M. High current liabilities relative to current assets create severe liquidity constraints, increasing the probability of insolvency if cash flow does not turn positive quickly. Regulatory uncertainty surrounding hemp-derived products poses a threat of sudden market contraction or legal challenges that could render existing product lines illegal overnight.
What is BUDZ's competitive advantage?
WEED, INC. leverages its specific knowledge of hemp-derived compliance frameworks and established relationships with state-level distributors to navigate a fragmented market. The company benefits from low capital intensity compared to traditional THC-focused cultivators, allowing for potential rapid pivots in product mix without massive fixed asset overhead. Operational flexibility allows management to adapt quickly to shifting state laws regarding hemp vs. marijuana classifications.
Related Companies
Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.